Note 13 - Subsequent Events (Details) (USD $)							0 Months Ended	6 Months Ended	0 Months Ended
	Jun. 30, 2013	Apr. 30, 2013	Dec. 31, 2012	Dec. 28, 2012	Jun. 08, 2010	Jul. 18, 2013 Subsequent Event [Member] Modified [Member] Summer 2013 Private Securities Offering [Member]	Jul. 18, 2013 Subsequent Event [Member] Summer 2013 Private Securities Offering [Member]	Jun. 30, 2013 Subsequent Event [Member] Clyra Medical Technology, Inc. [Member]	Jul. 17, 2013 Subsequent Event [Member] Chief Financial Officer [Member]
Note 13 - Subsequent Events (Details) [Line Items]
Sale of Stock, Number of Shares Issued in Transaction								100
Sale of Stock, Value, Gross (in Dollars)								$ 100,000
Sale of Stock, Value, Net (in Dollars)								$ 100,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				50,000	50,000				300,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)		1,833			0.50	0.30			0.30
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares									125,000
Share-based Compensation Arrangement By Share Based Payment Award, Remaining Options Expected to Incrementally Invest									25,000
Common Stock, Shares Authorized	200,000,000		200,000,000				3,000,000
Share Price (in Dollars per share)							$ 0.25
Over-allotment Option, Percentage							15.00%
Over-Allotment Option, Additional Shares							450,000
Common Stock, Shares Authorized, Including Over-Allotment Option							3,450,000